Violeta Lorén

452 total citations
18 papers, 366 citations indexed

About

Violeta Lorén is a scholar working on Genetics, Immunology and Molecular Biology. According to data from OpenAlex, Violeta Lorén has authored 18 papers receiving a total of 366 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Genetics, 7 papers in Immunology and 6 papers in Molecular Biology. Recurrent topics in Violeta Lorén's work include Inflammatory Bowel Disease (13 papers), Gut microbiota and health (6 papers) and Microscopic Colitis (5 papers). Violeta Lorén is often cited by papers focused on Inflammatory Bowel Disease (13 papers), Gut microbiota and health (6 papers) and Microscopic Colitis (5 papers). Violeta Lorén collaborates with scholars based in Spain, Switzerland and Germany. Violeta Lorén's co-authors include Eduard Cabré, Eugeni Domènech, Isabel Ojanguren, J Manyé, Josep Mañé, Miquel A. Gassull, Míriam Mañosa, Jordi Espadaler, Eva Pardina and Jordi Xaus and has published in prestigious journals such as Gastroenterology, PLoS ONE and International Journal of Molecular Sciences.

In The Last Decade

Violeta Lorén

17 papers receiving 360 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Violeta Lorén Spain 10 171 138 86 72 72 18 366
Cristina Hernández‐Chirlaque Spain 9 245 1.4× 103 0.7× 93 1.1× 54 0.8× 44 0.6× 13 486
Dominika Jakubczyk Poland 7 231 1.4× 81 0.6× 51 0.6× 62 0.9× 113 1.6× 12 365
Bani Ahluwalia Sweden 6 150 0.9× 103 0.7× 113 1.3× 62 0.9× 31 0.4× 8 403
Amira Metwaly Germany 9 316 1.8× 158 1.1× 63 0.7× 86 1.2× 35 0.5× 21 514
Andréa C. Alves Brazil 8 120 0.7× 61 0.4× 60 0.7× 68 0.9× 40 0.6× 12 321
Bryan Schaf United States 3 291 1.7× 54 0.4× 83 1.0× 58 0.8× 61 0.8× 5 389
Young Ok Choi South Korea 13 198 1.2× 150 1.1× 98 1.1× 100 1.4× 161 2.2× 23 587
Chengfei Wu China 11 287 1.7× 75 0.5× 74 0.9× 45 0.6× 47 0.7× 14 515
F Herweck Germany 7 198 1.2× 56 0.4× 122 1.4× 70 1.0× 39 0.5× 9 461
Rohini Emani Finland 7 318 1.9× 104 0.8× 58 0.7× 37 0.5× 61 0.8× 7 460

Countries citing papers authored by Violeta Lorén

Since Specialization
Citations

This map shows the geographic impact of Violeta Lorén's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Violeta Lorén with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Violeta Lorén more than expected).

Fields of papers citing papers by Violeta Lorén

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Violeta Lorén. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Violeta Lorén. The network helps show where Violeta Lorén may publish in the future.

Co-authorship network of co-authors of Violeta Lorén

This figure shows the co-authorship network connecting the top 25 collaborators of Violeta Lorén. A scholar is included among the top collaborators of Violeta Lorén based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Violeta Lorén. Violeta Lorén is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Pardina, Eva, M. Dolores López‐Tejero, Violeta Lorén, et al.. (2023). P023 Immune-metabolic profiles of creeping fat in relation to degree of severity in Crohn’s disease postsurgical recurrence.. Journal of Crohn s and Colitis. 17(Supplement_1). i192–i194.
2.
Bartolí, Ramón, Violeta Lorén, Patri Vergara, et al.. (2023). Response Variability to Drug Testing in Two Models of Chemically Induced Colitis. International Journal of Molecular Sciences. 24(7). 6424–6424. 3 indexed citations
3.
Carrasco, Anna, Eva Tristán, Fernando Fernández‐Bañares, et al.. (2022). Mucosal Interleukin‐10 depletion in steroid‐refractory Crohn's disease patients. Immunity Inflammation and Disease. 10(10). e710–e710. 4 indexed citations
4.
Pardina, Eva, et al.. (2021). The Complex Relationship Between Microbiota, Immune Response and Creeping Fat in Crohn’s Disease. Journal of Crohn s and Colitis. 16(3). 472–489. 42 indexed citations
5.
Zabana, Yamile, Violeta Lorén, Eugeni Domènech, et al.. (2020). Transcriptomic identification of TMIGD1 and its relationship with the ileal epithelial cell differentiation in Crohn’s disease. American Journal of Physiology-Gastrointestinal and Liver Physiology. 319(2). G109–G120. 13 indexed citations
6.
Lorén, Violeta, Juan E. Naves, Míriam Mañosa, et al.. (2018). ANP32E, a Protein Involved in Steroid-Refractoriness in Ulcerative Colitis, Identified by a Systems Biology Approach. Journal of Crohn s and Colitis. 13(3). 351–361. 34 indexed citations
7.
Lorén, Violeta, J Manyé, M.C. Fuentes, et al.. (2016). Comparative Effect of the I3.1 Probiotic Formula in Two Animal Models of Colitis. Probiotics and Antimicrobial Proteins. 9(1). 71–80. 22 indexed citations
9.
Lorén, Violeta, E. Cabré, Eugeni Domènech, et al.. (2012). P026 Effect of Toll-like receptor-2 deficiency on transcriptomic profile in DSS-colitis. Journal of Crohn s and Colitis. 6. S21–S21. 1 indexed citations
10.
Carrasco, Anna, Josep Mañé, Rebeca Santaolalla, et al.. (2012). Comparison of lymphocyte isolation methods for endoscopic biopsy specimens from the colonic mucosa. Journal of Immunological Methods. 389(1-2). 29–37. 16 indexed citations
11.
Mañé, Josep, et al.. (2011). A mixture of Lactobacillus plantarum CECT 7315 and CECT 7316 enhances systemic immunity in elderly subjects. A dose-response, double-blind, placebo-controlled, randomized pilot trial.. PubMed. 26(1). 228–35. 51 indexed citations
12.
Lorén, Violeta, Eduard Cabré, Eugeni Domènech, et al.. (2011). Bacteria and spontaneous experimental colitis: immunological changes. European Journal of Clinical Investigation. 41(10). 1047–1053. 7 indexed citations
13.
Mañé, Josep, Violeta Lorén, Isabel Ojanguren, et al.. (2011). Therapeutic effect of antisecretory factor-rich egg yolk on the late phases of 2,4,6-trinitrobenzenesulphonic acid colitis in mice. British Journal Of Nutrition. 106(10). 1522–1528. 9 indexed citations
14.
Santaolalla, Rebeca, Josep Mañé, Violeta Lorén, et al.. (2010). Apoptosis resistance of mucosal lymphocytes and IL-10 deficiency in patients with steroid-refractory Crohnʼs disease. Inflammatory Bowel Diseases. 17(7). 1490–1500. 25 indexed citations
15.
Mañé, Josep, Violeta Lorén, Isabel Ojanguren, et al.. (2009). Lactobacillus fermentum CECT 5716 prevents and reverts intestinal damage on TNBS-induced colitis in mice. Inflammatory Bowel Diseases. 15(8). 1155–1163. 51 indexed citations
16.
Mañé, Josep, Violeta Lorén, Isabel Ojanguren, et al.. (2009). Partial Replacement of Dietary (n-6) Fatty Acids with Medium-Chain Triglycerides Decreases the Incidence of Spontaneous Colitis in Interleukin-10–Deficient Mice. Journal of Nutrition. 139(3). 603–610. 40 indexed citations
17.
Santaolalla, Rebeca, Josep Mañé, Violeta Lorén, et al.. (2009). S1746 IL-10/TNFα Antagonism in the Intestinal Mucosa of IBD Patients. Relation with Steroid Response. Gastroenterology. 136(5). A–261. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026